Navigation Links
LifeCare Holdings, Inc. Announces Second Quarter Results
Date:8/14/2009

== ======== Schedule 4 Condensed Consolidated Statements of Cash Flows For the six months ended June 30, 2008 and 2009 (In thousands) (Unaudited) 2008 2009 ---- ---- Cash flows from operating activities: Net loss $(7,044) $(348) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization 6,634 6,474 Provision for doubtful accounts 2,448 3,107 Equity compensation amortization 147 160 Gain on early extinguishment of debt - (84) Gain on the disposal of assets - (2) Equity in loss of joint venture - 537 Changes in operating assets and liabilities: Patient accounts receivable 3,603 (5,411) Other current assets (857) (192) Other assets 472 288 Estimated third-party payor settlements (10,348) (8,773) Accounts payable and accrued expenses 1,902 (1,885) Other liabilities 1,091 (1,218) ----- ------ Net cash used in operating activities (1,952) (7,347) ------ ------ Cash flows from investing activities: Purchases of property and equipment (10,558) (2,605) Sale lease
'/>"/>
SOURCE LifeCare Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. LifeCare Holdings, Inc. Announces Third Quarter Results
2. LifeCare Hospitals of Wisconsin Unveils Center for Advanced Wound Healing
3. LifeCare Holdings, Inc. Announces Year-end Results
4. LifeCare Holdings, Inc. Names McAlister Chairman and CEO
5. LifeCare Holdings, Inc. Announces First Quarter Results
6. LifeCare Wins Breastfeeding-Friendly Business Award from Connecticut Breastfeeding Coalition
7. LifeCare Hospitals Names New Vice President of Marketing
8. LifeCare Holdings, Inc. Announces Year-End Results
9. The Female Health Company / HLL Lifecare Limited Receive National AIDS Control Organization of India Order for 1.5 Million FC2 Female Condoms
10. LifeCare Holdings, Inc. Announces First Quarter Results
11. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...constructive Surgery...In Brief is distributed mon...current journal news from the American Society of ...s highlighted here, or to arrange an interview wit...ions at (847) 228-9900 or media@plasticsurgery.org...2009 -- Yes, Plastic Surgeons Have Plastic Surgery...
(Date:11/23/2009)...-ThousandsofpeoplewithiPhoneshavealreadydownloaded...tesbettermanagetheirdiseasethroughabetterunderstan...managetheirbloodsugar.Nowit,sbecomeeveneasierthrou... RocheDiabetesCare,themakeroftheACCU-CHEK®lin...partneredwithMYLEstoneHealth,thedeveloperofGlucose...
(Date:11/23/2009)..., Reportlinker.comannouncesthatanewmarketresearch...w.reportlinker.com/p0165298/Childrens-Food-and-Dri...novation-2nd-Edition.html#utm_source=prnewswire&am..., Despitethegrowingattentionbeingpaidtotheworld,sa...groupthatcannotbeoverlooked.Childrenagedbetween5an...
(Date:11/23/2009)...G.Schwade,M.D.announcesthenewlyenhancedCyberKnifee...enterofMiami,( www.cyberknifemiami.com ). ,, ...dintensedoseofradiationthatkillscancercellswithnoi...lastfrom30minutestoonehour,andisusuallycompletedin...CenterintheSoutheasternU.S.,theMiamifacilityhasled...
(Date:11/23/2009)...rtlinker.comannouncesthatanewmarketresearchreporti...MarketTrends ,, http://www.reportlinker.com/...tm_source=prnewswire&utm_medium=pr&utm_cam...suchasSARS,outbreakoffluandbioterrorismhavefurther...ventingthespreadofinfections.Allthesefactorshaveco...
Breaking Medicine News(10 mins):Health News:Plastic and Reconstructive Surgery...In Brief 2Health News:Plastic and Reconstructive Surgery...In Brief 3Health News:ACCU-CHEK(R) Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy.com 2Health News:ACCU-CHEK(R) Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy.com 3Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 2Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 3Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 4Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 5Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 6Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 7Health News:Reportlinker Adds Hand Sanitizers - US Market Trends 2Health News:Reportlinker Adds Hand Sanitizers - US Market Trends 3Health News:Reportlinker Adds Hand Sanitizers - US Market Trends 4
...ishing a common stomach-dwelling bacterium makes t... Many people would benefit from chronic usage// of...ke aspirin and diclofenac. Not only do these drugs... drawback. They may lead to stomach bleeding and u...
...rts have long thought depression could be bad for ...erous it can be. Brenda Penninx, a US gerentologis...e of 55//- both with and without heart disease- fo...eart disease as were patients who weren't depresse...
...dark winter months motivate binge eating in certai...ersity of Irvine have been looking at the factors ...rders, where binge eating is a significant symptom...different from the comfort eating that many of us ...
...cing body temperature by just a few degrees minimi...hen the heart suddenly stops - cardiac arrest - th...d of oxygen. //Even if the person survives, they r... it after a cardiac arrest. Doctors in Vienn...
...do you know when someone who talks about suicide w... difficulty deciding which depressed patients need... they have found a way to assess risk: a blood tes... the final step. So says psychiatrist William Cory...
...unfrozen ready-to-eat meals could lead to the resu...d. Advances in freezing have made botulism a rare ...cientists, a new generation of ready-to-eat foods/...oking of foods, some botulism poisoning in recent ...
Other Medicine News:
(Date:11/23/2009)..., NOVATO,Calif.,Nov.23/PRNewswire-FirstCall/-...(Nasdaq: RPTP ),todayannouncedresultsfromaPhase2bc...inebitartrate("DRCysteamine")inpatientswithnephrop...theUniversityofCalifornia,SanDiego("UCSD")GeneralC...,pharmacokineticsandpharmacodynamicsofasingledoseo...
(Date:11/23/2009)..., EMERYVILLE,Calif.,Nov.23/PRNewswire-FirstCa... )("NTI")announcedtodaythatitsboardofdirectorshasd...monstock,whichwillbepaidonDecember9,2009tostockhol...xtraordinarydividendfollowsstockholderapprovalofth...ionanddissolutionandanearlierextraordinarydividend...
(Date:11/20/2009)..., , WAYNE, Pa., Nov. 20 /PRNewswire-FirstCal...announced the results for its fiscal first quarter...uarter of fiscal 2010, product revenue decreased a...ng the three-month period ended September 30, 2009... The Company reported the decreased net revenue of...
Breaking Medicine Technology:Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 5Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share 2Escalon(R) Reports First Quarter Fiscal 2010 Results 2Escalon(R) Reports First Quarter Fiscal 2010 Results 3Escalon(R) Reports First Quarter Fiscal 2010 Results 4Escalon(R) Reports First Quarter Fiscal 2010 Results 5Escalon(R) Reports First Quarter Fiscal 2010 Results 6Escalon(R) Reports First Quarter Fiscal 2010 Results 7Reminder program dramatically increases mammography rates Kaiser Permanente study finds 51578 1Reminder program dramatically increases mammography rates Kaiser Permanente study finds 51578 2Reminder program dramatically increases mammography rates Kaiser Permanente study finds 51578 3FAIR CEO Blasts Kaiser Foundation 26amp 3B Public Agenda HIV AIDS Study Results as 26quot 3BAbsolute Nonsense 26quot 3B 51573 1FAIR CEO Blasts Kaiser Foundation 26amp 3B Public Agenda HIV AIDS Study Results as 26quot 3BAbsolute Nonsense 26quot 3B 51573 2FAIR CEO Blasts Kaiser Foundation 26amp 3B Public Agenda HIV AIDS Study Results as 26quot 3BAbsolute Nonsense 26quot 3B 51573 3FAIR CEO Blasts Kaiser Foundation 26amp 3B Public Agenda HIV AIDS Study Results as 26quot 3BAbsolute Nonsense 26quot 3B 51573 4Eliminating polio requires global coordinated effort Health Affairs article highlights risks rewards of eradication 51569 1Eliminating polio requires global coordinated effort Health Affairs article highlights risks rewards of eradication 51569 2Eliminating polio requires global coordinated effort Health Affairs article highlights risks rewards of eradication 51569 3Eliminating polio requires global coordinated effort Health Affairs article highlights risks rewards of eradication 51569 4Eliminating polio requires global coordinated effort Health Affairs article highlights risks rewards of eradication 51569 5
...pr 16, 2007 - Amgen,(Nasdaq:AMGN) today presented ...bo-controlled Phase 3 study evaluating the,efficac...the,treatment of anemia in patients with active ca...the 103 study"). Aranesp is not,approved for use b... were presented in an oral session at the 2007 Ame...
...nt not met; plausibly,confounded by survival benef...K, April 16, 2007 /PRNewswire-FirstCall/ -- ImClon...mpany today,announced detailed results from the EP...Phase III trial - comparing ERBITUX(R),(Cetuximab)...ith,metastatic colorectal cancer (mCRC) who failed...
Other Medicine Technology:Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 2Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 3Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 4Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 5Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 6Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 7Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 2Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 3Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 4Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 5Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 6Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 7Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 8Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 9
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Keeler Sport Frames
Medicine Products: